Clinical Data and Roche sign high-throughput sequencing services deal
This article was originally published in Clinica
Roche Diagnostics and Clinical Data today announced an agreement to co-market a range of genome sequencing services, using a 454 Genome Sequencer FLX (GS FLX) system to be installed at one of the European facilities of Clinical Data's Cogenics division. The GS FLX, developed by 454 Life Sciences, of Branford, Connecticutt, promises a "state-of-the-art, high-throughput" operation.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.